Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. It works to eliminate viruses and prolong lifespan using carbohydrate drug design in the fields of Glycovirology, Hypoxia, and Degenerative Diseases. The company is also developing treatments for hypoxic conditions, necrosis, and degenerative diseases that utilize the carrying of oxygen to affected areas for stroke, wound, and brain damage treatment.